Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

Virology

Volumn 267, Issue 1, 2000, Pages 8-16

  Kaneko, Hiroshi ^a   Bednarek, Ilona ^a   Wierzbicki, Andrzej ^a   Kiszka, Irena ^a   Dmochowski, Marian ^a   Wasik, Thomas J ^a   Kaneko, Yutaro ^b   Kozbor, Danuta ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENCAPSULATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; LAMINA PROPRIA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; VACCINATION; VIRUS RESISTANCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; RNA VIRUSES; VACCINIA; VACCINIA VIRUS;

EID: 0034141366     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0093     Document Type: Article

References (32)

1. Alexander-Miller M. A., Leggatt G. R., Berzofsky J. A. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA. 93:1996;4102-4107.
2. Antón L. C., Yewdell J. W., Bennink J. R. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:1997;2535-2542.
3. Barouch D. H., Santra S., Steenbeke T. D., Zheng X. X., Perry H. C., Davies M.-E., Freed D. C., Craiu A., Strom T. B., Shiver J. W., Letvin N. L. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1998;1875-1882.
4. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J. Clin. Invest. 102:1998a;2072-2081.
5. Belyakov I. M., Derby M. A., Ahlers J. D., Kelsall B. L., Earl P., Moss B., Strober W., Berzofsky J. A. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc. Natl. Acad. Sci. USA. 95:1998b;1709-1714.
6. Chen S. C., Jones D. H., Fynan E. F., Farrar G. H., Clegg J. C. S., Greenberg H. B., Herrmann J. E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761.
7. Cranage M. P., Whatmore A. M., Sharpe S. A., Cook N., Polyanskaya N., Leech S., Smith J. D., Rud E. W., Dennis M. J., Hall G. A. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology. 229:1997;143-154.
8. Earl P. L., Broder C. C., Long D., Lee S. A., Peterson J., Chakrabarti S., Domes R. W., Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:1994;3015-3026.
9. Earl P. L., Koenig S., Moss B. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:1991;31-41.
10. Eldridge J. H., Staas J. K., Meulbroek J. A., McGhee J. R., Tice T. R., Gilley R. M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:1991;287-294.
11. Etchart N., Buckland R., Liu M. A., Wild T. F., Kaiserlian D. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78:1997;1577-1580.
12. Hedley M. L., Curley J., Urban R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat. Med. 4:1998;365-368.
13. Jones D. H., Corris S., McDonald S., Clegg J. C. S., Farrar G. H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15:1997;814-817.
14. Karacostas V., Nagashima K., Gonda M. A., Moss B. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA. 86:1989;8964-8967.
15. Kmieciak D., Bednarek I., Takiguchi M., Wasik T. J., Bratosiewicz J., Wierzbicki A., Teppler H., Pientka J., Hsu S. H., Kaneko Y., Kozbor D. The effect of epitope variation on the profile of cytotoxic T lymphocyte responses to the HIV envelope glycoprotein. Int. Immunol. 10:1998a;1789-1799.
16. Kmieciak D., Wasik T. J., Teppler H., Pientka J., Hsu S. H., Takahashi H., Okumura K., Kaneko Y., Kozbor D. The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis. J. Immunol. 160:1998b;5676-5683.
17. Levine M. M., Kaper J. B., Black R. E., Clements M. L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:1983;510-550.
18. Mackett M., Smith G. L., Moss B. Vaccinia virus: A selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA. 79:1982;7415-7419.
19. Mathiowitz E., Jacob J. S., Jong Y. S., Carino G. P., Chickering D. E., Chaturvedi P., Santos C. A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414.
20. Miller C. J., Alexander N. J., Sutjipto S., Lackner A. A., Gettie A., Hendrickx A. G., Lowenstine L. J., Jennings M., Marx P. A. Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63:1989;4277-4284.
21. Miller C. J., McGhee J. R., Gardner M. B. Mucosal immunity, HIV transmission, and AIDS. Lab. Invest. 68:1992;129-145.
22. Mora A. L., Tam J. P. Controlled lipidation and encapsulation of peptides as a useful approach to mucosal immunizations. J. Immunol. 161:1998;3616-3623.
23. Morris W., Steinhoff M. C., Russell P. K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine. 12:1994;5-11.
24. Phillips D. M., Zacharopoulos V. R., Tan X., Pearce-Pratt R. Mechanisms of sexual transmission of HIV: Does HIV infect intact epithelia. Trends Microbiol. 2:1994;454-458.
25. Reitter J. N., Desrosiers R. C. Identification of replication-competent strains of simian immunodeficiency virus lacking multiple attachment sites for N-linked carbohydrates in variable regions 1 and 2 of the surface envelope protein. J. Virol. 72:1998;5399-5407.
26. Robinson H. L. Nucleic acid vaccines: An overview. Vaccine. 15:1997;785-787.
27. Staats H. F., Nichols W. G., Palker T. J. Mucosal immunity to HIV-1: Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:1996;462-472.
28. + cytotoxic T lymphocytes by free antigenic peptide: A self-veto mechanism. J. Exp. Med. 183:1996;879-889.
29. Tighe H., Corr M., Roman M., Raz E. Gene vaccination: Plasmid DNA is more than just a blueprint. Immunol. Today. 19:1998;89-97.
30. Winer B. J. Design and analysis of factorial experiments. Maytham W., Shapiro A., Stern J. Statistical Principles in Experimental Design. 1971;399-400 McGraw-Hill, New York.
31. Wolff J. A., Malone R. W., Williams P., Chong W., Ascadi G., Jani A., Felgner P. L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
32. Yang N.-S., Burkholder J., Roberts B., Martinell B., McCabe D. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA. 87:1990;9568-9572.